Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Onkim Stem Cell Technologies is a leading Turkish biotechnology company specializing in the processing, storage, and production of stem cells. Founded in 2006 and based at the Istanbul Technical University Arı Teknokent, the company operates a state-of-the-art facility licensed by the Turkish Ministry of Health. Its core services include umbilical cord blood and tissue banking, as well as the manufacturing of mesenchymal stem cells (MSCs) and fibroblasts under Good Manufacturing Practice (GMP) standards. Onkim supports the medical community by providing high-quality cellular products for use in regenerative medicine, oncology, and various clinical applications. The company serves as a critical infrastructure provider for advanced cell-based therapies in Turkey and the surrounding region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Onkim Stem Cell Technologies.